Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|April 5, 2016
SMA OneTouch ICS
Advertisement
The SMA OneTouch ICS is a computerized, automated, viable air monitoring system that controls, calibrated and precise air sampling through individual or multiple SMA Atriums®. The SMA OneTouch ICS offers fully integrated, real-time control and monitoring of every individual sampling point, you will have the complete confidence that all viable sampling is being performed accurately and effectively. Sample parameters include facility wide, sample volume, sample duration, and vacuum pump status, all of which can be directly monitored on one single interface.
The ICS installation requires minimal tubing and wiring therefore simplifying installation into new and existing facilities. Additional features include, remote monitoring by using a variety of handheld, tablet, or computerized based devises and sounds immediate audible and visual alarms if the sample is compromised or aborted. It is, assuredly, the most comprehensive monitoring system in the industry.
Contact Details :
Veltek Associates, Inc.
Website:
E-mail:
Advertisement
Related to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
PharmTech’s Weekly Roundup—September 25, 2026
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5